Aktana

Aktana, founded in 2008, emerged as a pioneer in AI-driven field engagement for the life sciences sector.

Reviewed by 7wData
Share Email

On this page

Profile

AI-powered next-best-action platform for pharmaceutical sales teams to optimize HCP engagement.

Aktana, founded in 2008, emerged as a pioneer in AI-driven field engagement for the life sciences sector. The company specialized in next-best-action (NBA) platforms, helping pharmaceutical sales teams optimize their interactions with healthcare professionals (HCPs). Its proprietary Knowledge Nexus dataset, built from over 100 million field suggestions and 5,000+ tactics, powered predictive insights that demonstrated measurable impact, including a 36% lift in new prescription rates for clients.

Aktana's platform served 350+ brands across 1,000 deployments, with notable clients like Novo Nordisk, Pfizer, and Johnson & Johnson. In January 2026, PharmaForceIQ acquired Aktana to integrate its AI-driven field orchestration capabilities into a broader optichannel engagement platform. The acquisition marked a strategic shift, combining Aktana's field expertise with PharmaForceIQ's digital orchestration tools.

Pre-acquisition, Aktana had shown strong traction, with reported efficiency gains such as 20 minutes saved daily per rep and a 19% sales performance increase post-competitor launches. The company's technology was particularly valued in the U.S., LATAM, APAC, and EMEA markets, where it helped unify brand strategy and field execution.

Track Aktana and 240+ vendors.

335k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Global pharmaceutical companies
  • Biotech firms with field sales teams
  • Medical device manufacturers
  • Specialty pharma brands
  • Commercial and medical affairs teams in life sciences

Publicly disclosed clients

  • Novo Nordisk
  • Pfizer
  • Johnson & Johnson Innovative Medicine
  • Genentech
  • Sanofi

Strengths and what to watch

Strengths

  • Proprietary Knowledge Nexus dataset with 100M+ field suggestions and 5,000+ validated tactics
  • Demonstrated impact: 36% NBRx lift, 19% sales performance increase post-competitor launches
  • Integration with PharmaForceIQ expands optichannel capabilities beyond field engagement

Watch for

  • Post-acquisition integration risks with PharmaForceIQ's platform and culture
  • Dependence on large pharma clients, with potential concentration risk
  • Competition from CRM giants adding AI-driven field orchestration features

Recent moves

Key Information

Founded
2008

Frequently Asked Questions

What is Aktana?

Aktana is an AI-powered next-best-action platform designed to optimize pharmaceutical sales teams' engagement with healthcare professionals (HCPs). Founded in 2008, it leverages predictive insights to improve sales efficiency and effectiveness, serving over 350 brands globally.

How does Aktana improve pharmaceutical sales?

Aktana uses AI-driven insights to suggest optimal actions for sales teams, improving HCP engagement. It has demonstrated significant impact, including a 36% lift in new prescription rates and a 19% sales performance increase post-competitor launches.

What is the Knowledge Nexus dataset?

The Knowledge Nexus is Aktana's proprietary dataset, built from over 100 million field suggestions and 5,000+ validated tactics. It powers predictive insights that enhance sales strategies and improve engagement with healthcare professionals.

Who are Aktana's notable clients?

Aktana serves major pharmaceutical companies like Novo Nordisk, Pfizer, Johnson & Johnson Innovative Medicine, Genentech, and Sanofi. Its platform supports over 350 brands across 1,000 deployments globally.

What happened with Aktana's acquisition by PharmaForceIQ?

In January 2026, PharmaForceIQ acquired Aktana to integrate its AI-driven field orchestration capabilities into a broader optichannel engagement platform. This acquisition aimed to enhance cross-functional engagement impact for pharmaceutical clients.

Where is Aktana most effective?

Aktana's technology is particularly valued in the U.S., LATAM, APAC, and EMEA markets. It helps unify brand strategy and field execution, optimizing sales performance across diverse regions.

Sources

  1. www.prnewswire.com — Acquisition details, customer impact metrics, and proprietary dataset
  2. www.aktana.com — Customer base (350+ brands), product positioning, and client logos
  3. www.aktana.com — Industry recognition and platform capabilities
  4. www.sec.gov — Historical financial context pre-acquisition